Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-Dose Vemurafenib Plus Rituximab in Front-Line and Relapsed or Refractory Hairy Cell Leukemia: The Scripps Regimen.

Blood advances·2026
Same author

A novel JAK1 variant in chronic eosinophilic leukaemia with response to benralizumab.

British journal of haematology·2026
Same author

Glucagon Like Peptide 1 Receptor Agonists and Age-Related Macular Degeneration Incidence.

Ophthalmology. Retina·2026
Same author

Characterization of Pentosan Polysulfate Sodium Maculopathy With Fluorescence Lifetime Imaging.

Retina (Philadelphia, Pa.)·2026
Same author

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Blood·2026
Same author

Artificial intelligence based assessment of treatment response in wet age related macular degeneration using paired OCT angiography.

Scientific reports·2026

Related Experiment Video

Updated: Jun 1, 2026

Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma
06:20

Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma

Published on: January 12, 2024

Primary intraocular lymphoma: a review.

Gregory S Vosganian1, Saskia Boisot, Kathrin I Hartmann

  • 1Division of Hematology/Oncology, Scripps Clinic, 10666 N. Torrey Pines Road, La Jolla, CA 92037, USA. vosganian.gregory@scrippshealth.org

Journal of Neuro-Oncology
|June 1, 2011
PubMed
Summary

Primary intraocular lymphoma (PIOL) is a rare cancer. This case study details a patient with bilateral PIOL who achieved remission but later experienced brain recurrence, highlighting treatment challenges.

More Related Videos

Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine
08:00

Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine

Published on: June 24, 2019

Intravitreous Injection for Establishing Ocular Diseases Model
05:37

Intravitreous Injection for Establishing Ocular Diseases Model

Published on: October 1, 2007

Related Experiment Videos

Last Updated: Jun 1, 2026

Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma
06:20

Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma

Published on: January 12, 2024

Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine
08:00

Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine

Published on: June 24, 2019

Intravitreous Injection for Establishing Ocular Diseases Model
05:37

Intravitreous Injection for Establishing Ocular Diseases Model

Published on: October 1, 2007

Area of Science:

  • Ophthalmology
  • Hematology
  • Oncology

Background:

  • Primary intraocular lymphoma (PIOL) is a rare non-Hodgkin lymphoma, often classified as a subtype of primary central nervous system lymphoma.
  • Understanding PIOL's unique presentation and behavior is crucial for timely diagnosis and effective management.

Observation:

  • A 65-year-old immunocompetent woman was diagnosed with bilateral PIOL without evidence of systemic disease.
  • The patient achieved a 16-month remission following initial treatment.

Findings:

  • Despite initial remission, the patient experienced a recurrence of PIOL in the brain.
  • This case underscores the potential for PIOL to spread intracranially, even after apparent systemic control.

Implications:

  • Current diagnostic criteria and treatment strategies for PIOL in immunocompetent patients require careful consideration.
  • Further research into optimal therapeutic approaches is needed to improve long-term outcomes and prevent central nervous system relapse.